Navigation Links
ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2007 Financial Results
Date:3/13/2008

ADVENTRX Pharmaceuticals, Inc.

(A Development Stage Enterprise)

Summary Consolidated Financial Information

(In 000s except for per share data)

Consolidated Statement of

Operations Data:

Three months ended Twelve months ended

December 31, December 31,

2007 2006 2007 2006

(unaudited) (unaudited)

Revenues $-- $-- $500 $--

Operating expenses:

Research and

development 3,887 3,060 15,934 12,001

In-process research

and development -- -- -- 10,422

Selling, general and

administrative 1,884 1,691 8,679 7,236

Depreciation and

amortization 48 49 198 177

Total operating

expenses 5,819 4,800 24,811 29,836

Loss from operations (5,819) (4,800) (24,311) (29,836)

Interest income 438 455 2,169 1,164

Loss before income taxes (5,381) (4,345) (22,142) (28,672)

Provision for income

taxes -- -- -- --

Net loss $(5,381) $(4,345) $(22,142) $(28,672)

Net loss per share -

basic and diluted $(0.06) $(0.05) $(0.25) $(0.39)

Weighted average shares -

basic and diluted 90,253 83,092 89,913 73,988

Balance Sheet Data:

2007 2006

Total cash and investments
'/>"/>

SOURCE ADVENTRX Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
2. ADVENTRX Pharmaceuticals to Present at the 2007 Thomas Weisel Partners Healthcare Conference
3. ADVENTRX Pharmaceuticals to Present at the 20th Annual Bear Stearns Healthcare Conference
4. ADVENTRX Announces ANX-514 Clinical Development Plan Affirmed by the FDA
5. ADVENTRX Pharmaceuticals to Present at the ThinkEquity Partners Fifth Annual Growth Conference
6. ADVENTRX Pharmaceuticals to Present at the 2007 UBS Global Life Sciences Conference
7. ADVENTRX to Present ANX-514 Preclinical Data at 2007 AACR-NCI-EORTC International Conference
8. ADVENTRX Pharmaceuticals to Present at the 2007 BIOInvestor Forum
9. ADVENTRX Appoints Vice President of Commercialization
10. ADVENTRX Pharmaceuticals Reports Third Quarter 2007 Financial Results
11. ADVENTRX Announces Consolidation of Clinical and Management Positions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... Diego, CA (PRWEB) December 23, 2014 ... where their Twitter followers can submit their #HolidayInTheLab ... themselves and their lab mates. , For those struggling ... lab mates, the Pipette.com Holiday in the Lab Contest ... Pipette.com Twitter followers to send pictures of ...
(Date:12/24/2014)... , Dec. 23, 2014 Vermillion, ... focused on gynecologic disease, announced today that investors ... , Birchview Fund LLC and several Vermillion directors ... unregistered shares of Vermillion,s common stock and warrants ... in a private placement.  Under ...
(Date:12/24/2014)... Sigma-Aldrich Corporation (NASDAQ: SIAL ... the Hart-Scott-Rodino Antitrust Improvements Act (HSR Act) in ... 2014, thereby completing the U.S. HSR Act antitrust ... the Company by Merck KGaA, Darmstadt, Germany.  ... to closing the transaction, which remains subject to ...
(Date:12/24/2014)... NEW YORK , Dec. 23, 2014 ... pilot study of mazindol in children with attention deficit/hyperactivity ... in December 2014 . The paper, ... with attention deficit/hyperactivity disorder" ( Konofal et al, ... 1;8:2321-2332. eCollection 2014 ) shows that mazindol might ...
Breaking Biology Technology:Major Pipette Distributor Pipette.com Announces their Holiday in the Lab Contest 2Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 2Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 3Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 4Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 5Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 2Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 3Redefining ADHD: A New Approach & A Shift of Paradigm in ADHD Therapeutics 2Redefining ADHD: A New Approach & A Shift of Paradigm in ADHD Therapeutics 3
... State University researchers have developed a new method for ... are using this simple, fast, and low-temperature process to ... chemicals (TICs) and biological warfare agents. The researchers ... journal Materials Chemistry and Physics . Patricia ...
... protein calmodulin specifically targets and steers the activities of ... our cells, thus playing a role in physiologically important ... muscle contraction But just how it distinguishes between target ... at the Technische Universitaet Muenchen (TUM) have enabled them ...
... Researchers at the Georgia Institute of Technology, collaborating ... Hospital of Philadelphia, have developed a tool for ... the predicted effects of different surgical approaches. By ... patient,s specific anatomy, physicians can compare how alternative ...
Cached Biology Technology:New way to make sensors that detect toxic chemicals 2New way to make sensors that detect toxic chemicals 3Single-molecule technique captures calcium sensor calmodulin in action 2MRI simulation of blood flow helps plan child's delicate heart surgery 2MRI simulation of blood flow helps plan child's delicate heart surgery 3MRI simulation of blood flow helps plan child's delicate heart surgery 4
(Date:12/10/2014)... SUNNYVALE, California , December 9, 2014 /PRNewswire/ ... Integrate with ITN,s BCARD Platform ... secure, cloud-based enterprise meeting scheduling solutions for business-to-business ... International, the world leader in mobile near-field communication ... solutions.      (Logo: http://photos.prnewswire.com/prnh/20140612/691055) , ...
(Date:12/3/2014)... Ariz. , Dec. 2, 2014 As ... hand readers, Inception Technologies is pleased to announce the ... easier for customers to collect the workforce data that ... problems that have been left by existing readers. Many ... user interface, connectivity and modern technology. Older models force ...
(Date:11/21/2014)... Nov. 20, 2014   Atmel® Corporation (NASDAQ: ... (MCU) and touch technology solutions, today launched the industry,s ... with the widest V cc range from 1.7V ... and faster I 2 C bus communication speeds, and ... memory making them ideal for consumer, industrial, computer, and ...
Breaking Biology News(10 mins):Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 2Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 3Inception Technologies to Release New Biometric Reader 2Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 2Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 3Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 4
... , SAN ANTONIO, Texas, U.S.A. Scientists at The ... on to something that should bring joy to sunbathers ... combinations, have the ability to suppress skin cancer development ... research, supplements and creams or sunscreens may be developed, ...
... A team of UK researchers, funded by the ... released the first sequence coverage of the wheat genome. ... genome and makes a significant contribution to efforts to ... of UK farming. The genome sequences released comprise ...
... generation of neutron research at Indiana University Bloomington has ... for Standards and Technology. A recently awarded NIST grant ... years to support cooperative research activities between the Low ... National Center for Neutron Research, located in Gaithersburg, Md. ...
Cached Biology News:A step toward a new sunscreen? 2A step toward a new sunscreen? 3UK researchers release draft sequence coverage of wheat genome 2UK researchers release draft sequence coverage of wheat genome 3IU physics facility awarded $5 million for cooperative neutron research 2